Toralizumab Antibody
Toralizumab (IDEC-131) is a humanized anti-CD40L monoclonal antibody composed of human IgG1/kappa chains. It suppresses immune responses by blocking CD40-CD40L interactions and has been investigated in preclinical and clinical studies for autoimmune conditions like systemic lupus erythematosus.
Product Specifications
Target
TNF
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
5.65 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
148.43 (kD)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog